INS and Insulin resistance: HepG2 cells expressing IR-Dendra2 were exposed to physiologic levels of insulin (0.1 nM) to maintain insulin sensitivity, or pathologic levels of insulin (3 nM)48–50,57 to promote insulin resistance (Fig. 4a).